chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Client presented receive Pfizer Booster.  client was in observation area when she alerted PHN she was feeling dizzy. Client sat in zero gravity chair without assistance. Client told RN that she only had cookies for breakfast and had water. Client stated that she has no medical conditions and no allergies, and no reactions to vaccines, only history of anxiety attacks. Client denied itching, shortness of breath, trouble swallowing. Client was AAOx3. Water, juice and graham crackers were provided to client, and she proceeded to eat and drink snacks without any issues. Vitals BP 133/71 HR 76 02 99%. Client denied having any reactions to the Pfizer Series she had received.  Vitals BP 134/76 HR 81 02 99%. Client stated she felt her head ?heavy? but no head pain, and had blurriness in both eyes. Client stated that head heaviness is what she experiences when she has an anxiety attack, as well as sweating, numbness on shoulders but stated she wasn?t having those symptoms now.  RN asked client if her symptoms were improving, client stated the head heaviness and dizziness was going away, but blurriness was still in her eyes. Client requested to be lifted from lying position to a sitting position in zero gravity chair. Client was able to sit up with no problem. Both pupils were reactive to light. Vitals at 1345 BP 135/72 HR 81 02 97%. At 1352 Vitals BP 134/71 HR 82 02 99%. 400 Vitals BP 139/84 HR 76 02 100%. At 1400 client was asked by , PHN was asked if her symptoms were improving, client stated her dizziness, head heaviness, and blurred vision were gone. And stated, ?sitting up helped.? RN stated if she had no more symptoms and felt better, she could leave vaccination site.  RN educated client on Emergency room precautions for returning or worsening symptoms . Client verbalized understanding and left vaccination site in a steady gait.
Had my shot at 11:33. By 4:00 pm. I was having difficulty breathing, swelling in my throat. I took an antihistamine. After awhile that went away. Then that night around 8. My skin around my eyes started puffing up. And a white then yellow mucus started in my eyes. Later that night I started to have a horrible headache. In the morning I called my Dr. I was told to take Alive, I did.  I was out of pain around 11 the next day.
I would like to know why the vaccines are not working against covid-19, my wife, 2 daughters and I have followed the recommendations and we vaccinated and even so we contracted the virus; I would like to know why the vaccines are not working against covid-19, my wife, 2 daughters and I have followed the recommendations and we vaccinated and even so we contracted the virus; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (005570). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "I would like to know why the vaccines are not working against covid-19, my wife, 2 daughters and I have followed the recommendations and we vaccinated and even so we contracted the virus". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: unknown result, notes: contracted the virus. The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200015111 Same reporter/event/drug; different patient.;US-PFIZER INC-202200015112 Same reporter/event/drug; different patient.;US-PFIZER INC-202200015110 Same reporter/event/drug; different patient.
From pneumonia shot: within 1 hr of injection arm became very sore, then achy, then painful to use. At site of injection arm slightly swollen, very painful to touch. Symptoms lasted approx 6 days.
Injection site redness and soreness immediately after administration lasting 2+ days. Low grade fever, moderate to severe muscle and joint aches and fatigue lasting 36 hours; starting approx. four hours after administration.
Chills with VIOLENT shivering for several hours, strong enough to spasm chest and back muscles into charlie horse.  mild headache for 30 hours, fever.
This spontaneous report was received from a healthcare worker (also reported as office manager) refers to multiple unspecified patients of unknown demographics. No relevant medical history of the patients was reported. On unspecified dates the multiple unspecified patients were vaccinated with (Oka/Merck) VARIVAX (strength, dose, route, site of administration and lot number were not reported). There were no concomitant medications reported. It ws reported that the multiple unspecified patients were administered with (Oka/Merck) VARIVAX that was stored improperly on unknown dates. There were no adverse effects reported.  It was unspecified whether the patient had sought any medical attention. There was  no product quality complaint involved.   Follow up information has been received from office manager, who stated she may call back for fax information as it become available. Also , reported that M-M-R II was not mentioned int he original call, but did experience a temperature excursion. No further information was available at that time.   Follow up information as received from office manager refers to a 17 monrhs old patient. On 03-JUN-2014 the patient was vaccinated with a dose of improperly   stored M-M-R II (lot # J012818, expiration date 10-OCT-2015) (strength, dose, route and site of administration were not reported). This is one of several reports from the same source. Additional information has been requested.
Fever, red skin, was told was normal.  Next few days fever, non-stop screaming, vomiting.  Within a few days, broke out in pustules all over body.  Colic and screaming persisted for 9 months, developmental landmarks at the tail end of normal, stimming around 6 months, autism symptoms very early.
PAIN IN RIGHT HIP/JOINT RADIATING DOWN LEG/SHOULDER JOINT PAIN RADIATING DOWN ARM; SLIGHT ILLNESS; SLIGHT DIZZINESS; This spontaneous report received from a patient concerned a 46 year old male. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: OH1A21A expiry: UNKNOWN) dose was not reported, administered on 05-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 06-APR-2021, the subject experienced slight dizziness. On 07-APR-2021, the subject experienced slight illness. On 10-APR-2021, the subject experienced pain in right hip/joint radiating down leg/shoulder joint pain radiating down arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from pain in right hip/joint radiating down leg/shoulder joint pain radiating down arm on 17-APR-2021, and the outcome of slight dizziness and slight illness was not reported. This report was non-serious.
Itching, swelling with blistering reported, observed on 5/16/2012, slight swelling at site with healing blister noted. No pain on 5/16/2012. Self treated with OTC meds to manage discomfort.
Got the vaccine and I still got shingles/Suspected vaccination failure; Got shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 18th Apr 2022 Reporter's Comments: This case was reported by a consumer via interactive digital media. The case was reported by patient. The patient got the vaccine and still got shingles. No guarantees. Additional Supportive Information: This case was considered as suspected vaccination failure since details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles not given. The follow up would not be possible since no contact details provided.
Arm pain and soreness at site of vaccine about an hour after it was received. Sleeplessness during the night after receiving the shot. The next morning I felt achy, had a slight fever and had a mild headache. The site of the vaccine is red, very sore and 2 inches in diameter. It also continues into the second day. I took one ibuprofen to ease the symptoms. That has helped with all but the site soreness and redness.
Could not sleep the whole night; Little difficulty in breathing; Whole body pain; Lips and cheeks burning; Lips and cheeks burning; Difficulty talking; Headache; Chills; Nausea but couldn't vomit; Temp 101; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Could not sleep the whole night), DYSPNOEA (Little difficulty in breathing), PAIN (Whole body pain), ORAL DISCOMFORT (Lips and cheeks burning) and BURNING SENSATION (Lips and cheeks burning) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concurrent medical conditions included Diabetic. Concomitant products included METFORMIN and GLYBURIDE for Diabetes mellitus.   On 26-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Apr-2021, the patient experienced INSOMNIA (Could not sleep the whole night), DYSPNOEA (Little difficulty in breathing), PAIN (Whole body pain), ORAL DISCOMFORT (Lips and cheeks burning), BURNING SENSATION (Lips and cheeks burning), SPEECH DISORDER (Difficulty talking), HEADACHE (Headache), CHILLS (Chills), NAUSEA (Nausea but couldn't vomit) and PYREXIA (Temp 101). At the time of the report, INSOMNIA (Could not sleep the whole night), DYSPNOEA (Little difficulty in breathing), PAIN (Whole body pain), ORAL DISCOMFORT (Lips and cheeks burning), BURNING SENSATION (Lips and cheeks burning), SPEECH DISORDER (Difficulty talking), HEADACHE (Headache), CHILLS (Chills), NAUSEA (Nausea but couldn't vomit) and PYREXIA (Temp 101) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Apr-2021, Body temperature: 101 (High) High. On 26-Apr-2021, Oxygen saturation: 96 (normal) normal.         Treatment information was not provided by the reporter. Action taken with mRNA-1273 in response to the events was not applicable. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
8 hrs s/p vaccine. Pt developed frontal headache, night sweats and subjective fever. Pt seen by PCM in am with HA, photophobia, no nuchal rigidity but pain with eye movement
Chest pain, dizziness, high heart rate, headache, high blood pressure, light headed, nausea, palpitations.
Sometime between 05/15-05/17 I started having a rug-burn sensation in my left leg. On 05/21-2021 a shingles rash appeared on my leg (back of thigh) and lower back. Confirmed by dermatologist on teladoc. This is my second day of the rash and I was given an anti-viral medications at noon.
She received vaccine @ 12:01 pm. She waited for 15min minutes. She stated she left the building and was driving when she began to have tingling in face + lips. She also felt her chest was hot and it was tightening. She returned to the building where
FEVER; BODY ACHES; FLU LIKE SYMPTOMS; CHILLS; This spontaneous report received from a consumer concerned a patient of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown, and batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 06-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 06-MAR-2021, the subject experienced fever. On 06-MAR-2021, the subject experienced body aches. On 06-MAR-2021, the subject experienced flu like symptoms. On 06-MAR-2021, the subject experienced chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, body aches, flu like symptoms and chills was not reported. This report was non-serious.
Chest pain with evidence of pericarditis on EKG discharged with close PMD follow-up and NSAIDs
Patient is a 36 y.o. female with past medical history anxiety, depression, GERD, hypertension, type 2 diabetes who presented to Hospital via ambulance after calling 911 for respiratory failure.  Patient had been exposed to a person with COVID 4 days ago.  Progressively became more short of breath over the last few days.  She has an albuterol inhaler at home that did not offers much relief.  Upon arrival of EMS O2 sats in the 50% on room air.  Patient increased to 15 L non-rebreather and oxygen sats improved however patient remained tachypneic prompting BiPAP.  Hospitalized with respiratory failure d/t influenza A.
soreness in the upper part of the arm; headache presented in the upper right quadrant of the brain; fatigue; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 81-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included automobile accident (plate in upper left arm from car accident in January).   On 14th August 2020, the patient received the 2nd dose of Shingrix. In August 2020, less than a week after receiving Shingrix, the patient experienced pain in arm, headache and fatigue. On an unknown date, the outcome of the pain in arm, headache and fatigue were recovered/resolved.   It was unknown if the reporter considered the pain in arm, headache and fatigue to be related to Shingrix.  Additional details were reported as follows: The case was reported by the patient for herself. The patient received Shingrix in the right arm and had soreness in the upper part of the arm below the shoulder and fatigue. The headache presented in the upper right quadrant of the brain.  All symptoms resolved in 4 days. The reporter consented to follow up. This case has been linked with case US2020167500, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020167500:same repoter
3-4 INCH RED RASH AROUND INJECTION SITE, PAIN, INFLAMMATION.
pt recv vax; p/ 2nd dose, exp mild flu sx;recv 3rd dose & titer was neg on 6jan94; recv booster doses;
Pyrexia. a nsg practitioner reported that an infant received her  4th dose of Prevnar, as well as DTaP, IPV, Haemophilus B Conjugate, MMR, and Varivax vaccines on 4/16/01. Medical history includes diarrhea, sinusitis, and upper respiratory infection. On 4/17/01 the child developed  fever and thick green drainage.
By the 14th day after vaccination, patient has a sty on the bottom lid of eye. It itches and is painful. Lymph nodes under the underarms ache.
LOCAL REACTION: MILD SKIN RASH ON LEFT AND RIGHT DELTOID, BENADRYL HCl 12.5MG. GIVEN ONE DOSE OF 10ML PO.
Patient received both immunizations in the same arm. Later that night the patient woke up with tachycardia with HR in the 140s that persisted through the entire next day. He also mentioned that the entire upper half of his was bruised and swollen for several days following the immunizations.
medications included allopurinol (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN), latanoprost (MANUFACTURER UNKNOWN), esomeprazole (MANUFACTURER UNKNOWN), all for unknown indication received within two weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. It was reported that the patient received vaccine about 8 weeks after being exposed to COVID and about 4 weeks after recovery, on 22Mar2021 at 14:00, the patient experienced sore arm, fatigue, aches, chills, fever, mild nausea and loss of appetite for 2 days - began about 18 hours after injection, the events were worst about 24-30 hours after, later the events continued to be moderate for about 48 hours, finally recovered after 72 hours. The patient did not receive treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of sore arm, fatigue, aches, chills, fever, mild nausea and loss of appetite was recovered on 25Mar2021.  Information about lot/batch number cannot be obtained. No further information is expected.
Patient was fully vaccinated against COVID 19 on 2/19/21. Patient was found to be asymptomatic COVID positive prior to a surgery on 9/17/21. Upon surgical follow-up in clinic, patient was symptomatic with productive cough, dyspnea and hypoxemia requiring 2L nasal cannula 02. Patient was admitted to reporting hospital on 9/29/21 and remains hospitalized at this time.
w/in minutes of vax, pt devel systemic urticarial rash which lasted for approx 1 hr; pt very fretful for the hr; no tx initiated; pt recovered;
hives; rash around injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE URTICARIA (hives) and VACCINATION SITE RASH (rash around injection site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced VACCINATION SITE URTICARIA (hives) and VACCINATION SITE RASH (rash around injection site). At the time of the report, VACCINATION SITE URTICARIA (hives) and VACCINATION SITE RASH (rash around injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment medication included antibiotics.
Pt developed a raised knot where the vaccine was given. NO rash, NO itchiness associated.
Felt like the muscle was 'hardening' around the injection site; arm pain really bad; joints ached, strange kinda asymmetrical pains; nauseated; I have no evergy; Vomiting; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 11Aug2021 13:00 (Batch/Lot number: unknown) at the age of 41 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Migraines" (unspecified if ongoing); "Depression" (unspecified if ongoing); "Anxiety" (unspecified if ongoing); "anaplasmosis" (unspecified if ongoing), notes: several years. Concomitant medication(s) included: PRAZOSIN; TOPIRAMATE; BUPROPION; RAMELTEON. Vaccination history included: Bnt162b2 (1st Dose, time: 13:00, Location: Arm Left), administration date: 14Jul2021, when the patient was 41 years old, for COVID-19 Immunization, reaction(s): "oddly pleasant", "My neck Felt Warm And fuzzy", "I Felt High", "Some arm Pain". The following information was reported: MUSCLE DISORDER (non-serious) with onset 11Aug2021 18:00, outcome "not recovered", described as "Felt like the muscle was 'hardening' around the injection site"; PAIN IN EXTREMITY (non-serious) with onset 11Aug2021 18:00, outcome "not recovered", described as "arm pain really bad"; ARTHRALGIA (non-serious) with onset 11Aug2021 18:00, outcome "not recovered", described as "joints ached, strange kinda asymmetrical pains"; NAUSEA (non-serious) with onset 11Aug2021 18:00, outcome "not recovered", described as "nauseated"; ASTHENIA (non-serious) with onset 11Aug2021 18:00, outcome "not recovered", described as "I have no evergy"; VOMITING (non-serious) with onset 11Aug2021 18:00, outcome "not recovered", described as "Vomiting". Therapeutic measures were not taken as a result of muscle disorder, pain in extremity, arthralgia, nausea, asthenia, vomiting.  Additional information: Patient did not had covid prior vaccination. Patient was not tested post vaccination for covid. Patient didn't had any allergies. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination and since the vaccination the patient was not diagnosed and tested for COVID-19.  Follow-up (27Sep2021)This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
PATIENT RECEIVED A VACCINE FROM A PUNCTURED BUT REFRIGERATED VIAL 48 HOURS AFTER 1ST PUNCTURE. NO ADVERSE EVENTS REPORTED.
Initial report received on 21Jun06 from an investigator participating in the above mentioned trial. This 16 yr old female subject was diagnosed with juvenile rheumatoid arthritis 19 days after she had received a dose of Menactra, lot number U1780AA. The subject had also received concurrently a Decavac vaccine, lot number U1586A, and a Hep A vaccine, lot 0538R on 06Jan06. The subject's medical history was significant for poor weight gain that noted on the day of the vaccinations; her weight at the time was 81 pounds. A nutritional consult on 31Jan06 showed the subject to have a BMI of 13.7, and she was below the 75% of ideal body weight for her height of 5 feet and 6 inches. She was treated with Ensure supplements. The subject has a family history of juvenile rheumatoid arthritis in her mother at age 5 and her brother was with Behcet's disease. Nineteen days after receiving the vaccinations, the subject experienced swelling of the fingers in both hands, shoulder pain, morning stiffness; her joints were red, hot, swollen and painful, and she had hand, wrist, and elbow MCP synovitis with a soft mass on the dorsal aspect of her right wrist. Lab results 13 days after start of the symptoms showed Westergren ESR level at 49 (range 0-20 mm/hr), ANA screen was positive, RA 169 (range <43 iu/mL) and the lupus panel was negative. An x-ray of the right and left hand for painful swelling showed minimal PIP joint soft tissue changes with no evidence of erosive change. Further tests, 15 days later, showed CycCitrullinPet (CCP) IgG> 200 U and negative HLA-B27 antigen. Approximately 3 weeks after that, Westergren ESR was high at 46 (range 0-20 mm/hr). Four months after start of symptoms, Westergren ESR was 20 (range 0-20 mm/hr). Around the same time, the subject was evaluated by a physician and it was noted that the subject was feeling stronger and was able to get out of her chair easier. She had no morning stiffness but did have mild synovitis in MCP joints and wrists. The subject was treated with methotrexate and Naprosyn. The investigator considered this serious adverse event as a persistent or significant disability/incapacity. According to the investigator, the event of juvenile rheumatoid arthritis was related to the study vaccine as well as to the Decavac and Hep A vaccine. Due to the subject's significant family history, it was thought that the vaccines could have been possible triggers. Documents held by sender: X-rays, medical records.